Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T20:53:28.466Z.
Calculation as of: 2026-10-06T20:53:28.466Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a58e0fcb5c5c5211a6c4e1a8bb78ffa34e5085398ec1b7e8aba4a6f7bffe7660
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Unicycive Therapeutics, Inc.
Market Cap
$112.94M
PE Ratio
N/A
| NAME | MARKET CAP | PE RATIO |
|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | $112.94M | N/A |
| Caribou Biosciences, Inc. (CRBU)vs › | $112.57M | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | N/A |
| Genelux Corporation (GNLX)vs › | $113.89M | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.46M | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | N/A |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | N/A |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$4.23
Forward EPS (Est.)
$-1.26
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2025-08-14 | 22.05 |
| 2025-08-13 | 21.00 |
| 2025-08-12 | 20.24 |
| 2025-08-11 | 19.10 |
| 2025-08-08 | 19.48 |
| 2025-08-07 | 19.33 |
| 2025-08-06 | 19.76 |
| 2025-08-05 | 20.05 |
| 2025-08-04 | 19.95 |
| 2025-08-01 | 20.00 |
| 2025-07-31 | 20.67 |
| 2025-07-30 | 21.05 |
| 2025-07-29 | 21.05 |
| 2025-07-28 | 22.43 |
| 2025-07-25 | 23.19 |
| 2025-07-24 | 23.10 |
| 2025-07-23 | 21.95 |
| 2025-07-22 | 21.29 |
| 2025-07-21 | 21.43 |
| 2025-07-18 | 21.10 |
| 2025-07-17 | 22.14 |
| 2025-07-16 | 21.81 |
| 2025-07-15 | 22.00 |
| 2025-07-14 | 23.24 |
| 2025-07-11 | 23.86 |
| 2025-07-10 | 25.00 |
| 2025-07-09 | 25.62 |
| 2025-07-08 | 23.67 |
| 2025-07-07 | 22.33 |
| 2025-07-03 | 21.90 |
| 2025-07-02 | 22.10 |
| 2025-07-01 | 23.33 |
| 2025-06-30 | 22.71 |
| 2025-06-27 | 32.38 |
| 2025-06-26 | 28.29 |
| 2025-06-25 | 29.57 |
| 2025-06-24 | 33.05 |
| 2025-06-23 | 33.86 |
| 2025-06-20 | 30.19 |
| 2025-06-18 | 31.81 |
| 2025-06-17 | 32.71 |
| 2025-06-16 | 35.90 |
| 2025-06-13 | 32.43 |
| 2025-06-12 | 30.38 |
| 2025-06-11 | 30.00 |
| 2025-06-10 | 25.33 |
| 2025-06-09 | 42.86 |
| 2025-06-06 | 35.90 |
| 2025-06-05 | 36.62 |
| 2025-06-04 | 36.90 |
| 2025-06-03 | 36.33 |
| 2025-06-02 | 31.52 |
| 2025-05-30 | 27.90 |
| 2025-05-29 | 27.95 |
| 2025-05-28 | 29.10 |
| 2025-05-27 | 28.14 |
| 2025-05-23 | 26.33 |
| 2025-05-22 | 26.14 |
| 2025-05-21 | 27.14 |
| 2025-05-20 | 28.57 |
| 2025-05-19 | 28.86 |
| 2025-05-16 | 28.38 |
| 2025-05-15 | 26.24 |
